The Role of Contrast-Enhanced Imaging for Colorectal Cancer Management

[1]  M. Rengo,et al.  Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment , 2019, La Radiologia medica.

[2]  S. Nougaret,et al.  Locally recurrent rectal cancer: what the radiologist should know , 2019, Abdominal Radiology.

[3]  P. Pickhardt,et al.  CT Colonography in Preoperative Staging of Colon Cancer: Evaluation of FOxTROT Inclusion Criteria for Neoadjuvant Therapy. , 2019, AJR. American journal of roentgenology.

[4]  J. Han,et al.  Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: multi-readers’ diagnostic performance , 2019, European Radiology.

[5]  G. Choi,et al.  Diagnostic performance of MRI- versus MDCT-categorized T3cd/T4 for identifying high-risk stage II or stage III colon cancers: a pilot study , 2018, Abdominal Radiology.

[6]  G. Meurette.  Foxtrot Collaborative Group (2012) Lancet Oncol 13:1152–60 Feasibility of Preoperative Chemotherapy for Locally Advanced, Operable Colon Cancer: the Pilot Phase of a Randomised Controlled Trial , 2018, Côlon & Rectum.

[7]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[8]  L. Wyrwicz,et al.  Corrections to "Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". , 2018 .

[9]  L. Wyrwicz,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  Ahmed Kamel,et al.  Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  J. Meyerhardt,et al.  NCCN Guidelines Insights: Colon Cancer, Version 2.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization. , 2017, The British journal of radiology.

[13]  G. Beets,et al.  Advanced imaging to predict response to chemotherapy in colorectal liver metastases - a systematic review. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[14]  Damiano Caruso,et al.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer , 2017, Oncotarget.

[15]  G. Beets,et al.  Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. , 2017, European journal of radiology.

[16]  M. Rengo,et al.  MDCT of the liver in obese patients: evaluation of a different method to optimize iodine dose , 2017, Abdominal Radiology.

[17]  I. Swift,et al.  CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival. , 2017, Clinical radiology.

[18]  H. Grabsch,et al.  MRI for Local Staging of Colon Cancer: Can MRI Become the Optimal Staging Modality for Patients With Colon Cancer? , 2017, Diseases of the colon and rectum.

[19]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[20]  J. Lindebjerg,et al.  Local staging of sigmoid colon cancer using MRI , 2016, Acta radiologica open.

[21]  Harmeet Kaur,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Colorectal Cancer. , 2017, Journal of the American College of Radiology : JACR.

[22]  Steve Halligan,et al.  Correction to: Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2017, European Radiology.

[23]  M. Gonen,et al.  Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer , 2017, European Radiology.

[24]  Y. Ye,et al.  Prognostic significance of computed tomography-detected extramural vascular invasion in colon cancer. , 2016, World journal of gastroenterology.

[25]  Geerard L Beets,et al.  Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis. , 2016, AJR. American journal of roentgenology.

[26]  Nickolas Papanikolaou,et al.  Role of Magnetic Resonance Imaging in Primary Rectal Cancer-Standard Protocol and Beyond. , 2016, Seminars in ultrasound, CT, and MR.

[27]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  I. Swift,et al.  Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging. , 2016, The British journal of radiology.

[29]  S. Balyasnikova,et al.  Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management , 2016, Current Treatment Options in Oncology.

[30]  Jianping Lu,et al.  Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in rectal cancer and its correlation with tumor differentiation. , 2016, Molecular and clinical oncology.

[31]  M. Rengo,et al.  Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis , 2016, La radiologia medica.

[32]  P. Sammartino,et al.  Computerized System for Staging Peritoneal Surface Malignancies , 2015, Annals of Surgical Oncology.

[33]  Weijun Peng,et al.  Dynamic contrast‐enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer , 2015, Journal of magnetic resonance imaging : JMRI.

[34]  M. Philippens,et al.  Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation , 2015, Journal of magnetic resonance imaging : JMRI.

[35]  M. Philippens,et al.  Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer , 2015, Acta oncologica.

[36]  Myung Ah Lee,et al.  Correlation of dynamic contrast‐enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results , 2015, Journal of magnetic resonance imaging : JMRI.

[37]  Yoo-Seok Yoon,et al.  Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer , 2015, World Journal of Surgery.

[38]  D. Sahani,et al.  Computed tomography perfusion imaging as a potential imaging biomarker of colorectal cancer. , 2014, World journal of gastroenterology.

[39]  Koichi Nagata,et al.  Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. , 2014, World journal of gastroenterology.

[40]  A. Shinagare,et al.  Update on the role of imaging in management of metastatic colorectal cancer. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[41]  Jeong Min Lee,et al.  Dynamic contrast‐enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer , 2014, Journal of magnetic resonance imaging : JMRI.

[42]  G. Binefa,et al.  Colorectal cancer: from prevention to personalized medicine. , 2014, World journal of gastroenterology.

[43]  C. Düber,et al.  Rectal cancer: Dynamic contrast‐enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression , 2014, Journal of magnetic resonance imaging : JMRI.

[44]  Karin Haustermans,et al.  EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. , 2014, European journal of cancer.

[45]  Stuart A. Taylor,et al.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2018, European Radiology.

[46]  Dow-Mu Koh,et al.  Liver-specific agents for contrast-enhanced MRI: role in oncological imaging , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[47]  Myeong-Jin Kim,et al.  Perfusion Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients with Rectal Cancer: Correlation with Microvascular Density and Vascular Endothelial Growth Factor Expression , 2013, Korean journal of radiology.

[48]  M. Fusaro,et al.  Use of contrast agents in oncological imaging: magnetic resonance imaging , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[49]  B. Glimelius,et al.  Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer , 2013, Acta radiologica.

[50]  A. Graser,et al.  Current status on performance of CT colonography and clinical indications. , 2013, European journal of radiology.

[51]  M. Rengo,et al.  High concentration (400 mgI/mL) versus low concentration (320 mgI/mL) iodinated contrast media in multi detector computed tomography of the liver: a randomized, single centre, non-inferiority study. , 2012, European journal of radiology.

[52]  T. Hickish,et al.  Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012, The Lancet. Oncology.

[53]  Jacob G. Scott,et al.  Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012 .

[54]  Myeong-Jin Kim,et al.  Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer , 2012, European Radiology.

[55]  C. Bartolozzi,et al.  Preoperative rectal cancer staging with phased-array MR , 2012, Radiation oncology.

[56]  F. Caseiro-Alves,et al.  Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer. , 2012, Academic radiology.

[57]  M. Rengo,et al.  Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging , 2012, Abdominal Imaging.

[58]  C. Hassan,et al.  High positive predictive value of CT colonography in a referral centre. , 2011, European journal of radiology.

[59]  D. Tait,et al.  Diagnosis and management of colorectal cancer: summary of NICE guidance , 2011, BMJ : British Medical Journal.

[60]  F. Khosa,et al.  Hypervascular liver lesions on MRI. , 2011, AJR. American journal of roentgenology.

[61]  The optimal contrast media policy in CT of the liver. Part II: Clinical protocols , 2011, Acta radiologica.

[62]  M. Rengo,et al.  The optimal contrast media policy in CT of the liver. Part I: Technical notes , 2011, Acta radiologica.

[63]  T. Fu,et al.  Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features , 2011, La radiologia medica.

[64]  Preliminary experience with abdominal dual-energy CT (DECT): true versus virtual nonenhanced images of the liver , 2010, La radiologia medica.

[65]  I. Swift,et al.  Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer , 2010, The British journal of surgery.

[66]  C. Hassan,et al.  Colorectal cancer screening: the role of CT colonography. , 2010, World journal of gastroenterology.

[67]  H. Matsubara,et al.  Role of Perfusion CT in Assessing Tumor Blood Flow and Malignancy Level of Gastric Cancer , 2010, Digestive Surgery.

[68]  I. Nagtegaal,et al.  Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases , 2010, British Journal of Cancer.

[69]  J. Herman.  ACR Appropriateness Criteria. , 2010, Current problems in cancer.

[70]  L. Påhlman,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[71]  K. Coenegrachts.  Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions. , 2009, World journal of radiology.

[72]  K. Koda,et al.  Quantitative Measurement of Blood Flow Using Perfusion CT for Assessing Clinicopathologic Features and Prognosis in Patients with Rectal Cancer , 2009, Diseases of the colon and rectum.

[73]  I. Swift,et al.  CT staging of colon cancer. , 2008, Clinical Radiology.

[74]  Steve Halligan,et al.  Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis? , 2008, Radiology.

[75]  M. Rocco,et al.  Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer , 2008, Cancer.

[76]  Hong Lei Zhang,et al.  3D dynamic contrast‐enhanced MRI of rectal carcinoma at 3T: Correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis , 2008, Journal of magnetic resonance imaging : JMRI.

[77]  A. Norman,et al.  Accuracy of CT prediction of poor prognostic features in colonic cancer. , 2008, The British journal of radiology.

[78]  V. Goh,et al.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study , 2008, European Radiology.

[79]  Massimo Bellomi,et al.  CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. , 2007, Radiology.

[80]  K. Havenga,et al.  Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group , 2007, Annals of Surgical Oncology.

[81]  Geoff J M Parker,et al.  Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2007, Clinical Cancer Research.

[82]  A. Norman,et al.  Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials , 2007, British Journal of Cancer.

[83]  R. Beets-Tan,et al.  Conventional CT for the Prediction of an Involved Circumferential Resection Margin in Primary Rectal Cancer , 2004, Digestive Diseases.

[84]  C. Richards,et al.  Diagnostic value of multidetector row CT in rectal cancer staging: comparison of multiplanar and axial images with histopathology , 2006 .

[85]  C. Lepage,et al.  Epidemiology and Management of Liver Metastases From Colorectal Cancer , 2006, Annals of surgery.

[86]  W. Oyen,et al.  Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies , 2006, Annals of surgery.

[87]  D. Sahani,et al.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. , 2005, Radiology.

[88]  A. Padhani,et al.  Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer , 2001, The British journal of surgery.

[89]  C. Douglas Maynard,et al.  ACR Appropriateness Criteria , 2000 .

[90]  C. Reinhold,et al.  Helical CT of the liver: value of an early hepatic arterial phase. , 1995, Radiology.

[91]  P. Boer.  Estimated lean body mass as an index for normalization of body fluid volumes in humans. , 1984, The American journal of physiology.